克唑替尼治疗ALK 阳性NSCLC的疗效及对其融合基因、相关血清指标和预后的影响
吴 丽
The Comparison of Clinical Efficacy, Fusion Gene,Serum Markers and Prognosis of Crizotinib and Non-crizotinib treatment for EML4-ALK Positive Patients with Non Small Cell Lung Cancer
WU Li
标记免疫分析与临床
.
2018, (11): 1650
-1653
.
DOI: 10.11748/bjmy.issn.1006-1703.2018.11.018
